COMMUNIQUÉS West-GlobeNewswire

Carbios files its 2025 Universal Registration Document
29/04/2026
Clermont-Ferrand (France), 29 April 2026 (6:00 pm CEST). Carbios (Euronext Growth Paris: ALCRB) announces to its shareholders and the financial community that its 2025 Universal Registration Document, including: the [...]
CARBIOS annonce la mise à disposition de son Document d’enregistrement universel 2025
29/04/2026
Clermont-Ferrand (France), 29 avril 2026 (18h00 CEST). Carbios (Euronext Growth Paris : ALCRB) informe ses actionnaires et l’ensemble de la communauté financière que son Document d’enregistrement universel 2025, [...]
Availabilty of 2026 AGM preparatory documents
29/04/2026
Press Release Paris, 29 April, 2026 Combined General Meeting of May 27, 2026 Availability of preparatory documents EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 27 [...]
Modalité de mise à disposition des documents préparatoires à l'AG 2026
29/04/2026
Communiqué de presse Paris, le 29 avril 2026 Assemblée Générale du 27 mai 2026 Modalités de mise à disposition des documents préparatoires Les actionnaires d’EUROAPI sont invités à participer à l’Assemblée générale [...]
EUROBIO SCIENTIFIC : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
29/04/2026
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Paris, le 29 avril 2026 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro pour la transplantation [...]
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025
29/04/2026
EUROBIO SCIENTIFIC : Rapport Financier Annuel 2025 Pièce jointe EBS - RFA 2025
U.S. News & World Report Announces "Best of" 2026 Ratings for Legend Senior Living® Residences
29/04/2026
WICHITA, Kan., April 29, 2026 (GLOBE NEWSWIRE) -- U.S. News & World Report has named 27 residences of Legend Senior Living among its "Best of" for 2026 in their respective categories and 11 additional Legend [...]
Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference
29/04/2026
Novel procedure combines image-guided tumor cryolysis with intratumoral immunotherapy infusion, with early clinical findings in metastatic prostate cancer FORT LAUDERDALE, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- [...]
Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW)
29/04/2026
Oral presentation on the impact of concomitant steroid use in ulcerative colitis (UC) scheduled for May 5, 2026, at 9:30am CDT AUSTIN, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Cristcot, a clinical-stage pharmaceutical [...]
Beacon Therapeutics Announces Presentations at the ARVO 2026 Annual Meeting
29/04/2026
LONDON and CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (Beacon Therapeutics or the Company), a leading clinical-stage biotechnology company with a mission to save and [...]
SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
29/04/2026
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 [...]
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
29/04/2026
Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatment SARASOTA, Fla, April 29, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ: [...]
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
29/04/2026
New U.S. utility patent application targeting patient populations with demonstrated heightened responsiveness to ondansetron treatment, reinforcing Adial’s precision-medicine approach GLEN ALLEN, Va., April 29, 2026 ( [...]
Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
29/04/2026
Doheny scientists, clinician-scientists, and research fellows will present findings on eye disease, advanced imaging, artificial intelligence and more at the preeminent global vision research conference PASADENA, Calif [...]
Codexis to share RNA manufacturing advances at TIDES USA
29/04/2026
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS) a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, will present new data on ECO [...]
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
29/04/2026
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven Approved Phase 2a Human Clinical Trials Expected to Begin Patient [...]
Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
29/04/2026
THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET
29/04/2026
MOUNTAIN VIEW, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing [...]
Imviva Biotech to Present Clinical Data from Ongoing Phase 1/2 Study of CTA313 at the American Society of Gene & Cell Therapy's Annual Meeting
29/04/2026
Dual-targeted allogeneic CAR-T therapy demonstrates immune-reset mechanism and durable remission in system lupus erythematosus BOSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology [...]

Pages